NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm Biocartis Group today reported a 9 percent decline in full-year 2016 revenues, as a drop in collaboration revenue offset strong demand for its real-time PCR-based Idylla platform and test cartridges.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.